Bluebird bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $10,612 | $16,101 | $18,573 | $7,834 |
Gross Profit | -1,169 | -12,845 | -7,291 | -1,798 |
EBITDA | -39,744 | -59,393 | ||
EBIT | -55,088 | -75,919 | ||
Net Income | -60,808 | -81,393 | -69,804 | -88,514 |
Net Change In Cash | 10,612 | 16,101 | 18,573 | 7,834 |
Free Cash Flow | -69,208 | -66,311 | -76,451 | -19,051 |
Cash | 70,651 | 144,067 | 212,047 | 221,755 |
Basic Shares | 193,893 | 193,716 | 193,583 | 192,772 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $29,497 | $29,497 | $3,597 | $3,662 |
Gross Profit | -4,030 | -4,030 | -6,480 | -35,195 |
EBITDA | -167,161 | -215,559 | -556,926 | |
EBIT | -195,686 | -220,560 | -562,380 | |
Net Income | -211,913 | -211,913 | -266,578 | -562,638 |
Net Change In Cash | 29,497 | 29,497 | 3,597 | 3,662 |
Cost of Revenue | -167,036 | |||
Free Cash Flow | -244,103 | -244,103 | -366,161 | -658,642 |
Cash | 221,755 | 221,755 | 113,006 | 161,160 |
Basic Shares | 109,825 | 192,772 | 78,585 | 68,910 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.31 |
2024-06-30 | -$8.40 |
2024-03-31 | -$7.20 |
2023-12-31 | -$15.60 |
